Skip to main content
. 2018 Mar 9;13:1443–1456. doi: 10.2147/IJN.S147759

Figure 10.

Figure 10

Anti-cancer abilities of different formulations containing XY-4 or/and Bcl-xl siRNA against B16 cells after treatment for 72 h (CLP= cationic liposome).

  NODES